Maddie Sharma, M.D.


EDUCATION

 

1982-1986

Doctor of Medicine Tufts University School of Medicine Boston, Massachusetts

1978-1982

Bachelor of Science -Cum Laude Marquette University Milwaukee, Wisconsin


POST-GRADUATE TRAINING:

 

Jan.-June 2006

Genitourinary Cancer Fellowship Juravinski Cancer Centre Hamilton, Ontario

February 2004

Intensity Modulated Radiation Therapy ASTRO Course, San Diego, CA

January 1999

Prostate Brachytherapy Course University of South Florida, Tampa

1991-1993

Fellowship in Radiation Oncology Medical College of Wisconsin Milwaukee, Wisconsin

1989-1990

Chief Resident Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois

1987-1990

Radiation Oncology Residency Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois

1986 -1987

Internship (Transitional) Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois


BOARD CERTIFICATIONS

 

1993

American Board of Radiology Radiation Oncology


LICENSURE:

Massachusetts

Michigan

New York


ACADEMIC APPOINTMENTS:

 

2004-2005

Assistant Professor Roswell Park Cancer Institute Buffalo, New York

1995-2000

Assistant Professor Rush Medical College Chicago, Illinois

1991-1993

Instructor Medical College of Wisconsin Milwaukee, Wisconsin


HOSPITAL APPOINTMENTS:

 

1/2006-6/2006

Juravinski Cancer Center
Hamilton, Ontario
Genitourinary Cancer Fellowship

- 3-D conformal RT and IMRT.
- Prostate LDR brachytherapy
- Participation in RTOG & OCOG clinical trials
- Pinnacle treatment planning system
- IMPAC

2004-2005

Roswell Park Cancer Institute
Buffalo, New York
Assistant Professor

- Increased satellite facility practice from average of 10 to over 30 patients per day

2001-2003

Mercy Medical Center
Springfield, Massachusetts
Part time coverage

1998-2000

Illinois Masonic Medical Center
Chicago, Illinois
Clinical Director, Radiation Oncology

- Cancer Committee
- Radiation Safety Committee
- Tumor Board discussion leader

1995-2000

Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois Department of Radiation Oncology

- Chair, Quality Assurance Committee (led successful JCAHO accreditation)
- Residency Education Committee
- Chairmans Advisory Committee
- Initiated Chest Tumor Clinic
- Eastern Cooperative Oncology Group Radiation Oncology Liaison.

1993 -1995

Saint Margaret Mercy Healthcare Center
Hammond, Indiana
Department of Radiation Oncology


PROFESSIONAL AND SCIENTIFIC SOCIETIES:

American Society for Therapeutic Radiology and Oncology

College of Physicians and Surgeons of Ontario


RESEARCH WORKS:

 

Abstracts and Presentations:

Sharma M, Galinsky D, Murthy A, Griem K, Hartsell W. Primary Radiation Therapy to T1 and T2 Breast Cancer Following Conservative Surgery: Which Patients Should be Boosted? Presented at the Ninth Annual Meeting of the European Society for Therapeutic Radiology and Oncology, Montecatini, Italy, September 1990: 302. Poster presentation.

Sharma M, Murray K, Byhardt R, Wilson JF, Schultz C. T1 and T2 True Vocal Cord Carcinomas: An Analysis of Clinical and Technical Factors Affecting Local Control by Radiation Therapy. Proceedings of the Third International Conference on Head and Neck Cancer, San Francisco, CA, 1992:115. Paper presentation.

Sharma M, Gupta-Burt S, Faber P, Recine D, Bonomi P. Bronchopulmonary Toxicity in Stage III Non Small Cell Lung Cancer Patients Treated with Taxol Containing Chemotherapy and Concurrent Preoperative or Definitive Radiation Therapy. American Society for Therapeutic Radiology and Oncology, Orlando FL 1997: 312. Poster presentation.

Manuscripts:

Harland R, Sharma M, Rosenzweig D. Lung Carcinoma in a Patient with Lucite Sphere Plombage Thoracoplasty. Chest 1993; 103(4): 1295-1296.

Galinsky D, Sharma M, Hartsell W, Griem K, Murthy A. Primary Radiation Therapy to T1 and T2 Breast Cancer Followinq Conservative Surgery. Which Patients Should be Boosted? American Journal of Clinical Oncology. 1994; 16 (3): 60-63.

Bonomi P. Siddiqui S, Lincoln S, Sharma M, Recine D, Warren W, Faber LP. Escalating Doses of Taxol Combined with Carboplatin-Etoposide and Thoracic Radiotherapy as Pre-operative or Definitive Treatment for Stage III Non-Small Cell Lung Cancer. Seminars in Oncology, 1996: 23 (No.6, Suppl16, December): 102-107.

Cai J, Chu J, Recine D, Sharma M, Nguyen C, Rodebaugh R, Saxena V, Ali A. CT and PET Lung Image Registration and Fusion in Radiotherapy Treatment Planning using the Chamfer Matching Method. International Journal of Radiation Oncology Biology and Physics, 1999; 43(4): 883-891.

Protocols:

Phase II Trial of Preoperative Treatment with Paclitaxel/Carboplatin and Simultaneous Split Course Thoracic Radiation in Locally Advanced Non-Small Cell Lung Cancer, July 2000. (Sharma,M. and Bonomi, P.)

TEACHING ACTIVITIES:

 

Clinical Teaching:

1998-2000, Illinois Masonic Medical Center,internal medicine residents and medical students rotating through oncology.

1995-1997, Rush-Presbyterian-St. Luke's Medical Center. Daily resident supervision, (outpatient clinics, inpatient consultations, multidisciplinary clinics).

Conferences:

May 2004, Roswell Park Cancer Institute, faculty mentor for Radiation Oncology and Surgery resident debate.

1998-2000, Illinois Masonic Medical Center, moderator of weekly Tumor Board.

1995-1997, RPSLMC, resident teaching conferences, three hours per week, weekly Tumor Board, monthly Journal Club.

Classroom:

Spring Quarter, 1998, Medical Physics 542, Clinical Radiation Oncology, for medical physicists.

1993 -1994, Clinical Oncology, Indiana University Program in Radiation Therapy Technology. Received outstanding evaluation as a teacher.

 

About Your Treatments

About Your Disease

Treatment Center Information

Get To Know Your Doctor

Quality Assurance